High Tide Expands Global Footprint with Remexian Stake Acquisition
High Tide Inc. (Nasdaq: HITI), a pioneering enterprise in the cannabis sector, has recently made headlines by completing a major transaction that brings them a significant step closer to their goal of global expansion. The company has acquired a 51% interest in Remexian Pharma GmbH for approximately €26.4 million. This strategic move not only enhances High Tide's portfolio but also establishes its presence in Europe, a rapidly evolving market for cannabis.
With this acquisition, High Tide officially marks its entrance into the European market, previously dominated by Canadian companies. Raj Grover, the Founder and CEO of High Tide, expressed his enthusiasm, stating that this moment signifies a transformational chapter for the company. He believes that this transaction diversifies revenue streams and paves the way for further growth in European cannabis markets.
Transaction Highlights
The agreement was finalized under the terms of an Acquisition Agreement, which values Remexian at €53.4 million. This valuation corresponds to about 3.64065 times the annualized Adjusted EBITDA reported for the six months concluding on March 31, 2025. The acquisition is partially funded through a combination of cash, a loan, and shares in High Tide.
Specifically, the funding breakdown includes €7.65 million in cash and an equivalent amount through a loan with Remexian's sellers. The loan will mature by December 31, 2029, carrying a 7% annual interest rate, which is a favorable arrangement allowing early repayment without penalties. Moreover, High Tide issued approximately 5.86 million shares valued at €11.1 million based on the average closing price leading up to the transaction date.
Future Opportunities and Options
In an ambitious perspective for future growth, Remexian’s stakeholders have granted High Tide a Call Option, allowing the company to acquire the remaining 49% interest after 24 months. This option can be exercised at a future enterprise value tied to the annual Adjusted EBITDA of Remexian. There is also a Put Option available to Remexian’s owners, offering them a chance to sell their remaining stake back to High Tide under similar evaluative terms.
The establishment of such options not only reflects the confidence in Remexian’s potential but also demonstrates High Tide's proactive stance towards solidifying its global position in the cannabis industry.
About High Tide Inc.
High Tide, Inc. stands out as one of the foremost community-grown cannabis enterprises, focused on maximizing the potential of this multifaceted plant. Among its various dimensions, its subsidiary, Canna Cabana, is recognized as the second-largest cannabis retail brand globally. With operations spanning multiple aspects of the cannabis market, High Tide is uniquely positioned to cater to consumer needs through:
Retail Presence and Innovation
Canna Cabana holds the title as Canada's largest retail chain for cannabis, boasting a network of over 200 locations across several provinces. This brand became monumental as a pioneer in creating cannabis discount club experiences for customers.
Online Accessibility and Product Diversity
High Tide also excels in the e-commerce sector, operating well-known platforms like Grasscity.com and Smokecartel.com. They provide not only cannabis-related accessories but also stress the importance of innovation through technologies like Fastendr, which enhances the retail experience.
Recognitions and Future Plans
The company’s commitment to growth and excellence has garnered accolades over recent years, including listings in the Globe and Mail's “Canada's Top Growing Companies” for multiple consecutive years. As High Tide continues to innovate and expand, its path signifies a bright future in the cannabis sector. With recent developments in Europe, it is clear that High Tide is not only pursuing market dominance in Canada but is also determined to carve out a substantial presence in international markets.
Frequently Asked Questions
What is the significance of High Tide's acquisition of Remexian?
This acquisition marks High Tide's entry into the European cannabis market, diversifying their revenue sources and expanding their operational footprint.
How was the acquisition funded?
The acquisition was funded through a combination of cash, a seller loan, and shares issued by High Tide, totaling approximately €26.4 million.
What options did Remexian's stakeholders grant High Tide?
High Tide has been granted a Call Option and a Put Option concerning the remaining stakes in Remexian, allowing for future flexibility as the market evolves.
What awards has High Tide received recently?
High Tide has been recognized as one of Canada’s Top Growing Companies and ranked on the Financial Times list of America’s Fastest Growing Companies.
What does the future hold for High Tide?
With ongoing strategic initiatives and recent acquisitions, High Tide aims to solidify its position as a leader in the cannabis market, especially in Europe.
